Clinical Trials Browser

Phase 4 × Papillomavirus Infections × Engerix-B × Clear all

NCT00534638 2019-11-15

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

Phase 4 Completed

34,412 enrolled 21 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01082861 2010-03-19

TANGO

Phase 4 Terminated

Papillomavirus Infections